1
Toes-Zoutendijk, Esther, Vink, Geraldine, Nagtegaal, Iris D., Spaander, Manon C.W., Dekker, Evelien, van Leerdam, Monique E., Siesling, Sabine, Lansdorp-Vogelaar, Iris, Elferink, Marloes A.G.
Veröffentlicht in: Toes-Zoutendijk , E , Vink , G , COVID and Cancer-NL consortium , Nagtegaal , I D , Spaander , M C W , Dekker , E , van Leerdam , M E , Siesling , S , Lansdorp-Vogelaar , I & Elferink , M A G 2022 , ' Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands ' , European Journal of Cancer , vol. 161 , pp. 38-43 . https://doi.org/10.1016/j.ejca.2021.11.008;
2022
Veröffentlicht in: Toes-Zoutendijk , E , Vink , G , COVID and Cancer-NL consortium , Nagtegaal , I D , Spaander , M C W , Dekker , E , van Leerdam , M E , Siesling , S , Lansdorp-Vogelaar , I & Elferink , M A G 2022 , ' Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands ' , European Journal of Cancer , vol. 161 , pp. 38-43 . https://doi.org/10.1016/j.ejca.2021.11.008;
2022
2
Breekveldt, Emilie C.H., Lansdorp-Vogelaar, Iris, Toes-Zoutendijk, Esther, Spaander, Manon C.W., van Vuuren, Anneke J., van Kemenade, Folkert J., Ramakers, Christian R.B., Dekker, Evelien, Nagtegaal, Iris D., Krul, Myrtle F., Kok, Niels F.M., Kuhlmann, Koert F.D., Vink, Geraldine R., van Leerdam, Monique E., Elferink, Marloes A.G., van Bergeijk, Jeroen, Wiersma, Tjerk, van Grevenstein, Wilhelmina, Frasa, Marieke, van Gestel, Linda, Meijer, Gerrit
Veröffentlicht in: Breekveldt , E C H , Lansdorp-Vogelaar , I , Dutch National Colorectal Cancer Screening Working Group , Toes-Zoutendijk , E , Spaander , M C W , van Vuuren , A J , van Kemenade , F J , Ramakers , C R B , Dekker , E , Nagtegaal , I D , Krul , M F , Kok , N F M , Kuhlmann , K F D , Vink , G R , van Leerdam , M E , Elferink , M A G , van Bergeijk , J , Wiersma , T , van Grevenstein , W , Frasa , M , van Gestel , L & Meijer , G 2022 , ' Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands : a population-based study ' , The Lancet Gastroenterology and Hepatology , vol. 7 , no. 1 , pp. 60-68 . https://doi.org/10.1016/S2468-1253(21)00368-X;
2022
Veröffentlicht in: Breekveldt , E C H , Lansdorp-Vogelaar , I , Dutch National Colorectal Cancer Screening Working Group , Toes-Zoutendijk , E , Spaander , M C W , van Vuuren , A J , van Kemenade , F J , Ramakers , C R B , Dekker , E , Nagtegaal , I D , Krul , M F , Kok , N F M , Kuhlmann , K F D , Vink , G R , van Leerdam , M E , Elferink , M A G , van Bergeijk , J , Wiersma , T , van Grevenstein , W , Frasa , M , van Gestel , L & Meijer , G 2022 , ' Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands : a population-based study ' , The Lancet Gastroenterology and Hepatology , vol. 7 , no. 1 , pp. 60-68 . https://doi.org/10.1016/S2468-1253(21)00368-X;
2022